Egyptian Drug Authority · Egypt
DEA-EG-2026-0010
Tier 1 · Regulator-publishedClass IIIRecallStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(10) For 2026
- Date issued
- Jan 2026
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Colchicine 0.5 mg tablet BP 2022
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- Not published with the notice
- Expiry dates
- Not published with the notice
- Action type
- Recall
- Classification
- Class III as issued
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- Colchicine 0.5 mg tablet BP 2022
النصر
824725 - 834725
6/2028
صدور عدم مطابقة لهذهالتشغيلاتمن
معامل هيئة الدواء المصرية
سحب ووقف تداول وتحريز التشغيلاتمن
المستحضر الصادر لها عدم مطابقة
في حالة الشك في المستحضر الصيدلىيتم
الرجوع إلى هيئة الدواء المصرية سواء بالإتصال
بالخط الساخن 15301او الموقع الإلكترونى
الخاص بالهيئة.
يناير 2026
اسم المستحضر
سبب التحذير
الإجراءات
التصحيحية
نصائح
للمستهلكين
منشور
سحب
هذا التنبية خاص بالتشغيلات الواردة في المنشور فقط ولا ينطبق على
تداول المستحضر بشكل عام
رقم التشغيلات
الشركة المصنعة
تاريخ الانتهاءOriginal language: ar
- Notice text in English
- Recall, halt of circulation and seizure. Colchicine 0.5 mg tablets BP 2022, of El-Nasr, batches 824725 and 834725, expiry 6/2028. A finding of non-conformity has been issued for these batches by the Egyptian Drug Authority laboratories.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 3
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- de996f6e990c09cf96d0fd601ee4a509cd20e5354df765fbd929f4724aa94b5dSHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:48:44 UTC
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-0010: Colchicine 0.5 mg tablet BP 2022 — Recall, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-0010Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.